Plain-English translation of NCT06232434 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This clinical trial is testing a new medication called — a gel that is placed directly into the abdomen during surgery — to see if it can help treat advanced stomach cancer that has spread to the lining of the belly. Half of the participants will receive this new gel treatment along with standard chemotherapy, while the other half will receive only standard chemotherapy. The study will track how well the treatment works, how well patients tolerate it, and what side effects occur.
Stomach cancer that has spread to the abdomen is very serious and difficult to treat with chemotherapy alone. Researchers believe that placing medication directly where the cancer is — rather than relying only on systemic chemotherapy — might help patients live longer and have better outcomes.
You likely qualify if…
You likely don't qualify if…
If you are selected, you will undergo a surgical procedure (laparotomy or laparoscopy) to examine your abdomen. During this surgery, if you are in the treatment group, the new gel medication will be placed directly into your abdomen; if you are in the comparison group, you will receive standard chemotherapy only. After surgery, you will be examined daily while in the hospital and then visit the research center regularly for follow-up care. The study involves 120 patients total, with 60 receiving the new treatment and 60 receiving standard care.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Belarus